lymphoproliferative disorder

Showing 26 - 48 of 48

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Methemoglobinemia in Young Hematologic Cancer or Aplastic Anemia

Completed
  • Chronic Myeloproliferative Disorders
  • +8 more
  • Nashville, Tennessee
  • +1 more
Apr 13, 2017

Leukemia, Lymphoma, Lymphoproliferative Disorder Trial in United States (biological, drug, other, procedure)

Terminated
  • Leukemia
  • +5 more
  • anti-thymocyte globulin
  • +11 more
  • Lewes, Delaware
  • +9 more
Feb 6, 2017

Anemia, Leukemia, Lymphoma Trial in Rochester (darbepoetin alfa, epoetin alfa, fatigue assessment and management)

Completed
  • Anemia
  • +6 more
  • darbepoetin alfa
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
Dec 19, 2016

Chronic Myeloproliferative Disorders, Fatigue, Leukemia Trial in United States (American ginseng, )

Completed
  • Chronic Myeloproliferative Disorders
  • +9 more
  • American ginseng
  • placebo
  • Scottsdale, Arizona
  • +325 more
Dec 19, 2016

Cachexia, Lymphoma, Lymphoproliferative Disorder Trial in Canada, United States (Juven, Non-Juven Supplement)

Completed
  • Cachexia
  • +3 more
  • Juven
  • Non-Juven Supplement
  • Birmingham, Alabama
  • +249 more
Dec 6, 2016

Anemia, Leukemia, Lymphoma Trial in United States (epoetin alfa)

Completed
  • Anemia
  • +6 more
  • epoetin alfa
  • Scottsdale, Arizona
  • +17 more
Jul 15, 2016

Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Duarte (cytology specimen collection procedure,

Terminated
  • Brain and Central Nervous System Tumors
  • +9 more
  • cytology specimen collection procedure
  • +2 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Jun 3, 2015

Brain and CNS Tumors, Lymphoma, Lymphoproliferative Disorder Trial in Canada, United States (imetelstat sodium, laboratory

Completed
  • Brain and Central Nervous System Tumors
  • +4 more
  • imetelstat sodium
  • +2 more
  • Birmingham, Alabama
  • +22 more
Jan 29, 2014

Lymphoproliferative Disorder Trial in United Kingdom (therapeutic allogeneic lymphocytes)

Unknown status
  • Lymphoproliferative Disorder
  • therapeutic allogeneic lymphocytes
  • Birmingham, England, United Kingdom
  • +11 more
Dec 18, 2013

Lung Cancer, Lymphoma, Lymphoproliferative Disorder Trial in Los Angeles (gemcitabine HCl, motesanib diphosphate,

Unknown status
  • Lung Cancer
  • +3 more
  • gemcitabine hydrochloride
  • +2 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Sep 16, 2013

Studying Fentanyl in Patients With Cancer

Terminated
  • Brain and Central Nervous System Tumors
  • +10 more
  • fentanyl citrate
  • pharmacological study
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Apr 16, 2013

Myeloproliferative Disorders, Leukemia, Lymphoma Trial (aprepitant, ondansetron HCl)

Withdrawn
  • Myeloproliferative Disorders
  • +7 more
  • (no location specified)
Mar 29, 2013

Leukemia, Lymphoma, Lymphoproliferative Disorder Trial in New York (beta-glucan, rituximab)

Terminated
  • Leukemia
  • +2 more
  • beta-glucan
  • rituximab
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Mar 18, 2013

Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Seoul (donor natural killer cell infusion)

Completed
  • Brain and Central Nervous System Tumors
  • +8 more
  • donor natural killer cell infusion
  • Seoul, Korea, Republic of
    University of Ulsan, Asan Medical Center
Feb 18, 2013

Chronic Myeloproliferative Disorders, Infection, Leukemia Trial (Edetate Calcium Disodium, Ethanol,

Withdrawn
  • Chronic Myeloproliferative Disorders
  • +8 more
  • Edetate Calcium Disodium
  • +3 more
  • (no location specified)
Feb 13, 2013

Anemia, Leukemia, Lymphoma Trial in Los Angeles (epoetin alfa)

Completed
  • Anemia
  • +6 more
  • epoetin alfa
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Oct 3, 2012

Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in United States (educational intervention, Titrated

Completed
  • Brain and Central Nervous System Tumors
  • +10 more
  • educational intervention
  • +2 more
  • Hopkinsville, Kentucky
  • +10 more
Aug 4, 2012

Lung Cancer, Lymphoma, Lymphoproliferative Disorder Trial run by the CC (biological, drug, other)

Completed
  • Lung Cancer
  • +4 more
  • bevacizumab
  • +3 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
Mar 14, 2012

Quality of Life in Younger Leukemia and Lymphoma Survivors

Completed
  • Anxiety Disorder
  • +9 more
  • telephone-based intervention
  • +5 more
  • Cleveland, Ohio
    Case Medical Center, University Hospitals Seidman Cancer Center,
Aug 23, 2011

Anemia, Leukemia, Lymphoma Trial in Scottsdale, Rochester (biological, dietary supplement, drug, other)

Completed
  • Anemia
  • +6 more
  • darbepoetin alfa
  • +3 more
  • Scottsdale, Arizona
  • +1 more
May 13, 2011

Lymphoma, Lymphoproliferative Disorder, Small Intestine Cancer Trial in Buffalo (Src kinase inhibitor KX2-391, immunoenzyme

Completed
  • Lymphoma
  • +3 more
  • Src kinase inhibitor KX2-391
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 1, 2011

Autoimmune Disease, Lymphoproliferative Disorder Trial run by the NIAID (Fansidar (pyrimethamine and sulfadoxine))

Completed
  • Autoimmune Disease
  • Lymphoproliferative Disorder
  • Fansidar (pyrimethamine and sulfadoxine)
  • Bethesda, Maryland
    National Institute of Allergy and Infectious Diseases (NIAID)
Mar 3, 2008

Autoimmune Disease, Lymphatic Disease, Lymphoproliferative Disorder Trial run by the NIAID (Pyrimethamine)

Completed
  • Autoimmune Disease
  • +2 more
  • Bethesda, Maryland
    National Institute of Allergy and Infectious Diseases (NIAID)
Mar 3, 2008